4581 On Other Exchanges
Symbol
Exchange
4581 is not on other exchanges.

Executive Profile*

Ken Uehara

AgeTotal Calculated CompensationThis person is connected to 23 board members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background*

Mr. Ken Uehara has been Managing Director and Executive Director at Taisho Pharmaceutical Holdings Co., Ltd. since October 2011 and June 2013 repectively. Mr. Uehara serves as Executive Vice President and Director at Taisho Pharmaceutical Co., Ltd. and served as its Managing Director.

\

Corporate Headquarters*

3-24-1, Takada
Tokyo, -- 170-8655

Japan

Phone: 81 3 3985 2020
Fax: --

Board Members Memberships*

Executive Vice President and Director
2013-Present
MD & Executive Director

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Nick A. Caporella Chairman of the Board & CEO
National Beverage Corp.
--
Alison Mary Watkins BCom, FCA, SF Fin, FAICDGroup Managing Director and Executive Director
Coca-Cola Amatil Limited
A$3.8M
Manoj Kumar MD & Director
GlaxoSmithKline Consumer Healthcare Limited
52.6M
Jae-Hyuk Lee CEO & Vice Chairman
Lotte Chilsung Beverage Co.,Ltd.
--
Larry D. Young CEO, President & Executive Director
Dr Pepper Snapple Group, Inc.
$1.1M
Compensation as of Fiscal Year 2017.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TAISHO PHARMACEUTICAL HOLDIN, please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.